Effect of amitriptyline on the messenger RNA of thyroid hormone-responsive genes in rat cerebral tissue

Julio Bobes, Una D McCann

Research output: Contribution to journalArticle

Abstract

To determine the molecular mechanisms of the potentiating effect of thyroid hormones (TH) on the therapeutic efficacy of tricyclic antidepressants (TCA), the expression of two known TH-responsive mRNAs was measured in control rats and rats treated with triiodothyronine (T3, 10 μg/100 g for 10 days), amitriptyline (10 mg/kg for 10 days), or combined T3 and amitriptyline. Northern blot analysis was carried out to measure the cerebral tissue content of a novel translational repressor (NAT-1) and another thyroid hormone-responsive (THR) mRNA. Rats treated with the combination of T3 and amitriptyline had significantly higher NAT-1 expression (2691.1 ± 134.1 arbitrary units) than rats treated with T3 only (1688.5 ± 77.8) or with amitriptyline only (1452.5 ± 87.5) or the untreated control rats (731.3 ± 23.0), P <0.01. Amitriptyline treatment did not alter the expression of THR mRNA or THR protein in either control or T3-treated rats. It is concluded that alterations in the expression of selective T3 responsive genes in cerebral tissue could be a mechanism of the known T3 potentiation of the therapeutic efficacy of TCA.

Original languageEnglish (US)
Pages (from-to)333-338
Number of pages6
JournalCurrent Opinion in Psychiatry
Volume13
Issue number3
DOIs
StatePublished - 2000

Fingerprint

Amitriptyline
Thyroid Hormones
Messenger RNA
Genes
Tricyclic Antidepressive Agents
Triiodothyronine
Northern Blotting
Therapeutics
Proteins

Keywords

  • Depression
  • Gene expression
  • Thyroid hormones
  • Tricyclic antidepressants

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Effect of amitriptyline on the messenger RNA of thyroid hormone-responsive genes in rat cerebral tissue. / Bobes, Julio; McCann, Una D.

In: Current Opinion in Psychiatry, Vol. 13, No. 3, 2000, p. 333-338.

Research output: Contribution to journalArticle

@article{9a7398772b294afdb4f9508c820babb4,
title = "Effect of amitriptyline on the messenger RNA of thyroid hormone-responsive genes in rat cerebral tissue",
abstract = "To determine the molecular mechanisms of the potentiating effect of thyroid hormones (TH) on the therapeutic efficacy of tricyclic antidepressants (TCA), the expression of two known TH-responsive mRNAs was measured in control rats and rats treated with triiodothyronine (T3, 10 μg/100 g for 10 days), amitriptyline (10 mg/kg for 10 days), or combined T3 and amitriptyline. Northern blot analysis was carried out to measure the cerebral tissue content of a novel translational repressor (NAT-1) and another thyroid hormone-responsive (THR) mRNA. Rats treated with the combination of T3 and amitriptyline had significantly higher NAT-1 expression (2691.1 ± 134.1 arbitrary units) than rats treated with T3 only (1688.5 ± 77.8) or with amitriptyline only (1452.5 ± 87.5) or the untreated control rats (731.3 ± 23.0), P <0.01. Amitriptyline treatment did not alter the expression of THR mRNA or THR protein in either control or T3-treated rats. It is concluded that alterations in the expression of selective T3 responsive genes in cerebral tissue could be a mechanism of the known T3 potentiation of the therapeutic efficacy of TCA.",
keywords = "Depression, Gene expression, Thyroid hormones, Tricyclic antidepressants",
author = "Julio Bobes and McCann, {Una D}",
year = "2000",
doi = "10.1097/00001504-200005000-00016",
language = "English (US)",
volume = "13",
pages = "333--338",
journal = "Current Opinion in Psychiatry",
issn = "0951-7367",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Effect of amitriptyline on the messenger RNA of thyroid hormone-responsive genes in rat cerebral tissue

AU - Bobes, Julio

AU - McCann, Una D

PY - 2000

Y1 - 2000

N2 - To determine the molecular mechanisms of the potentiating effect of thyroid hormones (TH) on the therapeutic efficacy of tricyclic antidepressants (TCA), the expression of two known TH-responsive mRNAs was measured in control rats and rats treated with triiodothyronine (T3, 10 μg/100 g for 10 days), amitriptyline (10 mg/kg for 10 days), or combined T3 and amitriptyline. Northern blot analysis was carried out to measure the cerebral tissue content of a novel translational repressor (NAT-1) and another thyroid hormone-responsive (THR) mRNA. Rats treated with the combination of T3 and amitriptyline had significantly higher NAT-1 expression (2691.1 ± 134.1 arbitrary units) than rats treated with T3 only (1688.5 ± 77.8) or with amitriptyline only (1452.5 ± 87.5) or the untreated control rats (731.3 ± 23.0), P <0.01. Amitriptyline treatment did not alter the expression of THR mRNA or THR protein in either control or T3-treated rats. It is concluded that alterations in the expression of selective T3 responsive genes in cerebral tissue could be a mechanism of the known T3 potentiation of the therapeutic efficacy of TCA.

AB - To determine the molecular mechanisms of the potentiating effect of thyroid hormones (TH) on the therapeutic efficacy of tricyclic antidepressants (TCA), the expression of two known TH-responsive mRNAs was measured in control rats and rats treated with triiodothyronine (T3, 10 μg/100 g for 10 days), amitriptyline (10 mg/kg for 10 days), or combined T3 and amitriptyline. Northern blot analysis was carried out to measure the cerebral tissue content of a novel translational repressor (NAT-1) and another thyroid hormone-responsive (THR) mRNA. Rats treated with the combination of T3 and amitriptyline had significantly higher NAT-1 expression (2691.1 ± 134.1 arbitrary units) than rats treated with T3 only (1688.5 ± 77.8) or with amitriptyline only (1452.5 ± 87.5) or the untreated control rats (731.3 ± 23.0), P <0.01. Amitriptyline treatment did not alter the expression of THR mRNA or THR protein in either control or T3-treated rats. It is concluded that alterations in the expression of selective T3 responsive genes in cerebral tissue could be a mechanism of the known T3 potentiation of the therapeutic efficacy of TCA.

KW - Depression

KW - Gene expression

KW - Thyroid hormones

KW - Tricyclic antidepressants

UR - http://www.scopus.com/inward/record.url?scp=0034066019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034066019&partnerID=8YFLogxK

U2 - 10.1097/00001504-200005000-00016

DO - 10.1097/00001504-200005000-00016

M3 - Article

AN - SCOPUS:0034066019

VL - 13

SP - 333

EP - 338

JO - Current Opinion in Psychiatry

JF - Current Opinion in Psychiatry

SN - 0951-7367

IS - 3

ER -